Schedule 13D ownership disclosure
GoodRx Holdings Inc
Class A Common Stock · CUSIP: 38246G108
Event date: 2025-03-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Francisco Partners IV, L.P.Reported CIK 0001622902
Shares: 40,019,294 · Class: 24%
- Francisco Partners IV-A, L.P.Reported CIK 0001622908
Shares: 20,058,890 · Class: 12%
- Francisco Partners GP IV, L.P.Reported CIK 0001674067
Shares: 60,078,184 · Class: 36%
- Francisco Partners GP IV Management Limited
Shares: 60,078,184 · Class: 36%
- Francisco Partners Management, L.P.Reported CIK 0001197853
Shares: 60,078,184 · Class: 36%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-041231
- Form type
- SCHEDULE 13D/A
- Filer
- FRANCISCO PARTNERS IV, L.P.
- CIK
- CIK 1622902
- Filed
- Mar 18, 2025
- Reporting period
- Mar 16, 2025
- Description
- Schedule 13D beneficial ownership